These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

782 related articles for article (PubMed ID: 21267954)

  • 1. Direct comparison of the diagnostic value of point-of-care tests detecting heart-type fatty acid binding protein or glycogen phosphorylase isoenzyme BB in patients with acute coronary syndromes with persistent ST-segment elevation.
    Figiel Ł; Wraga M; Bednarkiewicz Z; Lipiec P; Smigielski J; Krzemińska-Pakuła M; Kasprzak JD
    Kardiol Pol; 2011; 69(1):1-6. PubMed ID: 21267954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heart-type fatty acid binding protein--a reliable marker of myocardial necrosis in a heterogeneous group of patients with acute coronary syndrome without persistent ST elevation.
    Figiel Ł; Kasprzak JD; Peruga J; Lipiec P; Drozdz J; Krzemińska-Pakuła M; Smigielski J
    Kardiol Pol; 2008 Mar; 66(3):253-9, discussion 260-1. PubMed ID: 18393112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic accuracy of quantitative heart-fatty acid binding protein assays compared with Cardiodetect(®) in the early detection of acute coronary syndrome.
    Charpentier S; Maupas-Schwalm F; Cournot M; Elbaz M; Ducassé JL; Bottela JM; Lauque D
    Arch Cardiovasc Dis; 2011 Oct; 104(10):524-9. PubMed ID: 22044705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigation of a multimarker approach to the initial assessment of patients with acute chest pain.
    McCann CJ; Glover BM; Menown IB; Moore MJ; McEneny J; Owens CG; Smith B; Sharpe PC; Young IS; Adgey JA
    Adv Ther; 2009 May; 26(5):531-4. PubMed ID: 19475367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel biomarkers in early diagnosis of acute myocardial infarction compared with cardiac troponin T.
    McCann CJ; Glover BM; Menown IB; Moore MJ; McEneny J; Owens CG; Smith B; Sharpe PC; Young IS; Adgey JA
    Eur Heart J; 2008 Dec; 29(23):2843-50. PubMed ID: 18682444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heart fatty acid-binding protein in combination with the 80-lead body surface potential map improves early detection of acute myocardial infarction in patients who are cardiac troponin T-negative at presentation.
    Daly MJ; McCann CJ; Owens CG; Harbinson MT; Adgey JA
    J Electrocardiol; 2011; 44(4):432-8. PubMed ID: 21529821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of a multimarker approach for patients presenting to hospital with acute chest pain.
    McCann CJ; Glover BM; Menown IB; Moore MJ; McEneny J; Owens CG; Smith B; Sharpe PC; Young IS; Adgey JA
    Am J Cardiol; 2009 Jan; 103(1):22-8. PubMed ID: 19101224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical assessment of heart-type fatty acid binding protein in early diagnosis of acute coronary syndrome.
    Valle HA; Riesgo LG; Bel MS; Gonzalo FE; Sanchez MS; Oliva LI
    Eur J Emerg Med; 2008 Jun; 15(3):140-4. PubMed ID: 18460953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of usefulness of heart-type fatty acid binding protein versus cardiac troponin T for diagnosis of acute myocardial infarction.
    Haltern G; Peiniger S; Bufe A; Reiss G; Gülker H; Scheffold T
    Am J Cardiol; 2010 Jan; 105(1):1-9. PubMed ID: 20102882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical assessment of ischemia-modified albumin and heart fatty acid-binding protein in the early diagnosis of non-ST-elevation acute coronary syndrome in the emergency department.
    Charpentier S; Ducassé JL; Cournot M; Maupas-Schwalm F; Elbaz M; Baixas C; Juchet H; Lang T; Lauque D
    Acad Emerg Med; 2010 Jan; 17(1):27-35. PubMed ID: 20078436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of human heart-type fatty acid-binding protein as an early diagnostic biochemical marker of myocardial necrosis in patients with acute coronary syndrome, and its comparison with troponin-T and creatine kinase-myocardial band.
    Ruzgar O; Bilge AK; Bugra Z; Umman S; Yilmaz E; Ozben B; Umman B; Meric M
    Heart Vessels; 2006 Sep; 21(5):309-14. PubMed ID: 17151819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heart fatty acid binding protein (H-FABP) as a diagnostic biomarker in patients with acute coronary syndrome.
    Gururajan P; Gurumurthy P; Nayar P; Srinivasa Nageswara Rao G; Babu S; Cherian KM
    Heart Lung Circ; 2010 Nov; 19(11):660-4. PubMed ID: 20674495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Diagnostic and prognostic value of heart-type fatty acid-binding protein (H-FABP), an early biochemical marker of myocardial injury].
    Bertinchant JP; Polge A
    Arch Mal Coeur Vaiss; 2005 Dec; 98(12):1225-31. PubMed ID: 16435602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic accuracy of heart-type fatty acid-binding protein for the early diagnosis of acute myocardial infarction.
    McMahon CG; Lamont JV; Curtin E; McConnell RI; Crockard M; Kurth MJ; Crean P; Fitzgerald SP
    Am J Emerg Med; 2012 Feb; 30(2):267-74. PubMed ID: 21208763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of the heart-type fatty acid binding protein in the early diagnosis of acute coronary syndrome and its comparison with troponin I and creatine kinase-MB isoform.
    Orak M; Ustündağ M; Güloğlu C; Ozhasenekler A; Alyan O; Kale E
    Am J Emerg Med; 2010 Oct; 28(8):891-6. PubMed ID: 20825920
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heart-type fatty acid-binding protein predicts long-term mortality and re-infarction in consecutive patients with suspected acute coronary syndrome who are troponin-negative.
    Viswanathan K; Kilcullen N; Morrell C; Thistlethwaite SJ; Sivananthan MU; Hassan TB; Barth JH; Hall AS
    J Am Coll Cardiol; 2010 Jun; 55(23):2590-8. PubMed ID: 20513600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic value of heart-type fatty acid binding protein determined by the rapid qualitative chromatographic immunoassay method for the detection of minor myocardial damage in patients presenting with non-ST elevation acute coronary syndrome.
    Çavuşoğlu Y; Gök B; Demirüstü C; Birdane A; Görenek B; Ata N
    Anadolu Kardiyol Derg; 2012 Nov; 12(7):584-90. PubMed ID: 22804980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Utilization of glycogen phosphorylase BB measurement in the diagnosis of acute coronary syndromes in the event of chest pain].
    Lacnák B; Stejskal D; Jedelský L; Karpísek M; Sprongl L
    Vnitr Lek; 2007 Nov; 53(11):1164-9. PubMed ID: 18277625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heart-type fatty acid binding protein (H-FABP) in patients in an emergency department setting, suspected of acute coronary syndrome: optimal cut-off point, diagnostic value and future opportunities in primary care.
    Willemsen RT; van Severen E; Vandervoort PM; Grieten L; Buntinx F; Glatz JF; Dinant GJ
    Eur J Gen Pract; 2015; 21(3):156-63. PubMed ID: 25751665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suspected acute coronary syndrome in the emergency room: Limited added value of heart type fatty acid binding protein point of care or ELISA tests: The FAME-ER (Fatty Acid binding protein in Myocardial infarction Evaluation in the Emergency Room) study.
    Bank IE; Dekker MS; Hoes AW; Zuithoff NP; Verheggen PW; de Vrey EA; Wildbergh TX; Timmers L; de Kleijn DP; Glatz JF; Mosterd A
    Eur Heart J Acute Cardiovasc Care; 2016 Aug; 5(4):364-74. PubMed ID: 25906779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.